2 small-cap growth stocks I’d buy with £2,000 today

These two growth stocks are under the radar and could deliver outsized returns, says G A Chester.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Small-cap growth stocks offer investors the potential for outsized returns. Judges Scientific (LSE: JDG), which released impressive annual results today, is one such stock I’d happily buy. And there’s another small-cap I’ll discuss, which still looks very buyable to me despite its share price having more than doubled in less than a year.

Attractive proposition

Judges Scientific owns 16 scientific instrument businesses, which are primarily UK-based but serve global niche markets, with long-term growth fundamentals. The group is listed on AIM and its shares are trading 4.6% higher at 2,270p, as I’m writing, on the back of today’s record results. Its market capitalisation is just under £140m.

It reported a 24.6% increase in revenue to £71.4m, including 17.7% organic growth, and a 55.5% rise in underlying earnings per share (EPS) to 131.9p. At the current share price, the price-to-earnings (P/E) ratio is 17.2. The performance was helped by “very favourable foreign exchange rates” but even so, the P/E looks cheap.

The company boasts a strong order book and has £10.7m cash on the balance sheet to help it pursue selective acquisitions, which are an integral part of its growth strategy. The businesses within the group can experience some short-term variability in performance but the long-term growth drivers make Judges an attractive proposition in my view.

Special situation

Although it counts familiar blue-chip names among its customers, packaging machinery specialist Mpac (LSE: MPAC) will be unknown to most readers. Until recently, this AIM-listed firm was called Molins. The change followed the disposal of the group’s tobacco machinery division and transfer of the Molins name.

I first tipped the company as a ‘special situation’ in June last year when the shares were trading at 101.5p. I put fair value at between 175p — based on pro forma net asset value (NAV) of £35.4m — and 197p. That latter figure was based on £51m forecast sales for the remaining business, valued at the same 0.78 times sales multiple at which the disposed-of business was sold. I upped my NAV estimate to £44.6m (221p a share) in November and suggested “the value on offer here could attract wider attention when the company releases its annual results (with a clean balance sheet) in early 2018.”

Those results showed revenue a little above forecast at £53.4m, giving a fair value of 207p a share on my 0.78 sales multiple, and NAV a little below my estimate at £42.8m, giving 212p a share. The shares are currently trading at 210p and the market cap is £42m.

Still value on offer?

The special situation has played out nicely but looking at the stock afresh, there still appears to be value on offer. According to Reuters, the consensus among City analysts is for EPS of 10.15p for the current year, followed by a 42% increase to 14.4p next year. This gives a P/E of 20.7, falling to 14.6, and a price-to-earnings growth (PEG) ratio of 0.35, which is well to the value side of the PEG fair value marker of one.

The company has net cash of £29.4m, a surplus of £17.6m on its UK pension scheme and deficit of £6.2m on its US one. However, there’s some risk due to the size of the gross pension assets and liabilities (both over £400m at the last reckoning), which potential investors should weigh up.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any of the shares mentioned. The Motley Fool UK has recommended Judges Scientific. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing For Beginners

4 actionable stock market investing habits that can boost my profits

Jon Smith looks at the stock market and explains how he picks the right shares to buy, running through a…

Read more »

Investing Articles

The Standard Chartered share price leaps on FY dividend and buyback news. Time to buy?

An 8% jump for a UK-listed bank on 2023 results? That's what just happened to the Standard Chartered share price.…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Can Lloyds shares get any cheaper?

Lloyds shares have fallen further following the release of the bank's 2023 results. This Fool senses now is a time…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

£7,000 of money to spare? Here’s how I’d aim to turn that into £1,000 in annual extra income

Christopher Ruane explains how he would aim to generate a four figure income to cushion his future, all with dividend…

Read more »

British union jack flag and Parliament house at city of Westminster in the background
Investing Articles

Is this stellar dividend growth stock the only no-brainer buy on the entire FTSE 100?

Picking shares requires careful thought and analysis, but this FTSE 100 growth stock appears to be pressing all the right…

Read more »

Investing Articles

I bought 422 Glencore shares in July and 232 in September. Here’s what they’re worth now

Glencore shares have had a rough ride leaving Harvey Jones out of pocket. Should he cut his losses or average…

Read more »

Man smiling and working on laptop
Investing Articles

Here’s why I’m investing most of my savings in FTSE 100 shares!

I think investing in FTSE 100 shares is one of the best ways that UK investors can make long-term returns.…

Read more »

Newspaper and direction sign with investment options
Investing Articles

When cheap markets meet favourable conditions, sentiment flips very quickly

London’s stock market is cheap — some sectors, even cheaper. Given a change in sentiment, the uprating could be substantial.

Read more »